Evidence map›Paper›PMID 32266164›Full record

ArticleFrontiers in cellular and infection microbiology2020

Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication.

Megan E May, Christopher W Pohlmeyer, Abena K Kwaa, Madeleine C Mankowski, Justin R Bailey, Joel N Blankson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. TCR-mimic bispecific antibodies to target the HIV-1 reservoir.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Megan E MayDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
Christopher W PohlmeyerDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
Abena K KwaaDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
Madeleine C MankowskiDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
Justin R BaileyDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
Joel N BlanksonDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Optimization of high throughput viral outgrowth assays for the detection of HIV-1 reservoirsR01AI140789 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BLANKSON, JOEL N · 2018 to 2021
$1.6M
A mouse viral outgrowth assay for the detection of residual HIV-1 reservoirsR01AI120024 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BLANKSON, JOEL N · 2015 to 2017
$1.2M
NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI120024NIAID NIH HHS R01 AI140789
6 · The paper itself

Abstract

Elite controllers or suppressors (ES) are HIV-1 infected individuals who maintain undetectable viral loads without anti-retroviral therapy. The HLA-B*57 allele is overrepresented in ES suggesting a role for HIV-specific CD8+ T cells in immune control. Natural killer (NK) cells also play a role in controlling viral replication, and genetic studies demonstrate that specific combinations of killer cell immunoglobulin-like receptor (KIR) alleles and HLA subtypes including HLA-B*57 correlate with delayed progression to AIDS. While prior studies have shown that both HIV-specific CD8+ T cells and NK cells can inhibit viral replication

Indexed as

HIV-1HIV InfectionsCD8-Positive T-LymphocytesHLA-B AntigensHumansKiller Cells, NaturalVirus ReplicationHLA-B57 antigenHLA-B AntigensCD8+ T cellsHIV-1NK cellsviral replicationviral suppression

Identifiers

PMID32266164
PMCPMC7098910
OpenAlexW3011368207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.